Innate Pharma's Series C Round

Innate Pharma raised a round of funding on August 09, 2004.

Innate Pharma is a biopharmaceutical company developing first-in-class drugs targeting innate immunity. The Company is currently developing three product platforms (gamma delta T cells, NK cells and T…

Articles about Innate Pharma's Series C Round: